Role of Adiponectin in prostate cancer

Role of Adiponectin in prostate cancer

ABSTRACT Obesity is defined as a chronic and excessive growth of adipose tissue. It has been associated with a high risk for development and progression of obesity-associated malignancies, while adipokines may mediate this association. Adiponectin is an adipose tissue-derived adipokines, with signif...

Full description

Bibliographic Details
Main Authors:	Xiaobo Hu, Cong Hu, Caiping Zhang, Min Zhang, Shiyin Long, Zhaohui Cao
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia
Series:	International Brazilian Journal of Urology
Subjects:	Prostatic Neoplasms Obesity Stress, Physiological
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000200220&lng=en&tlng=en

Similar Items

Role of native Thiol, total Thiol and dynamic Disulphide in diagnosis of patient with prostate cancer and prostatitis
by: Mehmet Solakhan, et al.

Involvement of CFTR in prostatitis and prostate cancer development.
Published: (2010)

Metabolic syndrome and prostatic disease: potentially role of polyphenols in preventive strategies. A review
by: Tommaso Castelli, et al.
Published: (2016-06-01)

Prostatic Inflammation in Prostate Cancer: Protective Effect or Risk Factor?
by: Alessandro Tafuri, et al.
Published: (2021-06-01)

Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer
by: Wenlv Shen, et al.
Published: (2004-05-01)

Clinical trials involving positron emission tomography and prostate cancer: an analysis of the ClinicalTrials.gov database
by: Nikola Cihoric, et al.
Published: (2018-06-01)

Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
by: Pietro Pepe, et al.
Published: (2015-10-01)

Pathological prognostic factors in prostate cancer
by: Cohen, Ronald Joseph
Published: (2017)

Review of Clinical Manifestations of Biochemically-advanced Prostate Cancer Cases
by: Edmund Chiong, et al.
Published: (2005-07-01)

Is possible to rule out clinically significant prostate cancer using PI-RADS v2 for the assessment of prostate MRI?
by: Publio Cesar Cavalcanti Viana, et al.

Outcomes following negative prostate biopsy for patients with persistent disease after radiotherapy for prostate cancer
by: Jacob H. Cohen, et al.
Published: (2010-02-01)

Clinical Significance of Serum Adipokines according to Body Mass Index in Patients with Clinically Localized Prostate Cancer Undergoing Radical Prostatectomy
by: Minyong Kang, et al.
Published: (2018-01-01)

Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: No
by: Benjamin T. Ristau, et al.

Role of miRNA-182 and miRNA-187 as potential biomarkers in prostate cancer and its correlation with the staging of prostate cancer
by: Brusabhanu Nayak, et al.

The role of transurethral resection of the prostate for patients with an elevated prostate-specific antigen
by: Hee Ju Cho, et al.
Published: (2014-12-01)

Is It Effective to Perform Two More Prostate Biopsies According to Prostate-Specific Antigen Level and Prostate Volume in Detecting Prostate Cancer? Prospective Study of 10-Core and 12-Core Prostate Biopsy
by: Byung Il Yoon, et al.
Published: (2012-05-01)

Survival of patients with prostate cancer
by: Fabienne Camilo da Silveira Pirajá, et al.
Published: (2013-03-01)

The performance of the new prognostic grade and stage groups in conservatively treated prostate cancer
by: Cheng Chen, et al.
Published: (2018-01-01)

Can we improve the detection rate of prostate cancer using standard 12‐core TRUS‐guided prostate biopsy? Focused on the location of prostate biopsy
by: Sangjun Yoo, et al.
Published: (2020-06-01)

Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: Yes
by: Walter Henriques da Costa, et al.

Assessment of serum level of prostate-specific antigen adjusted for the transition zone volume in early detection of prostate cancer
by: Marcos D. Ferreira, et al.
Published: (2005-04-01)

Induction of miR-765 by antiestrogen ICI 182,780 in prostate cancer cells.
Published: (2011)

Prostate-Specific Antigen fluctuation: what does it mean in diagnosis of prostate cancer?
by: Jun Seok Kim, et al.
Published: (2015-04-01)

Metastatic prostate cancer in the modern era of PSA screening
by: Philip A. Fontenot Jr, et al.

Retrospective study comparing six - and twelve-core prostate biopsy in detection of prostate cancer
by: Motoi Tobiume, et al.
Published: (2008-02-01)

Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer
by: Carlo Cattrini, et al.
Published: (2020-10-01)

Early stage prostate cancer: biochemical recurrence after treatment
by: Danielle A. Zanatta, et al.
Published: (2014-04-01)

Can microfocal prostate cancer be regarded as low-risk prostate cancer?
by: Seung Hwan Lee, et al.
Published: (2013-12-01)

The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer
by: Jongchan Kim, et al.
Published: (2017-09-01)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
by: Yong Hyun Park, et al.
Published: (2014-03-01)

The association of family history of prostate cancer with the diagnosis of clinically significant prostate cancer in Korean population
by: Jee Soo Park, et al.
Published: (2019-11-01)

The human gastrointestinal microbiota and prostate cancer development and treatment
by: Sybil Sha, et al.
Published: (2020-02-01)

Biological studies of fascin function in cancer cell invasion and cancer progression
by: Behmoaram, Emy.
Published: (2008)

Optimal use of prostate specific antigen for prostate cancer screening
by: Miočinović Ranko, et al.
Published: (2013-01-01)

Incidental prostate cancer diagnosed at radical cystoprostatectomy for bladder cancer: disease-specific outcomes and survival
by: Joshua B. Kaelberer, et al.
Published: (2016-09-01)

The impact of plasma zinc status on the severity of prostate cancer disease
by: Victor C. Wakwe, et al.
Published: (2019-05-01)

The role of extended prostate biopsy on prostate cancer detection rate: a study performed on the bench
by: Luciano Nesrallah, et al.
Published: (2008-10-01)

Potential Role of Exercise Induced Extracellular Vesicles in Prostate Cancer Suppression
by: Ying Zhang, et al.
Published: (2021-09-01)

Elevated prostate volume index and prostatic chronic inflammation reduce the number of positive cores at first prostate biopsy set: results in 945 consecutive patients
by: Antonio B. Porcaro, et al.

The Influence of Androgen Deprivation Therapy on Prostate Size and Voiding Symptoms in Prostate Cancer Patients in Korea
by: Hoon Choi, et al.
Published: (2016-12-01)